Cleavage of von Willebrand factor by ADAMTS-13 in vitro : effect of temperature and barium ions on the proteolysis kineticsPERUTELLI, Paolo; AMATO, Stefano; MOLINARI, Angelo C et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 8, pp 607-611, issn 0957-5235, 5 p.Article

Generation and Breakdown of Soluble Ultralarge von Willebrand Factor MultimersTURNER, Nancy; NOLASCO, Leticia; MOAKE, Joel et al.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 1, pp 38-46, issn 0094-6176, 9 p.Article

Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammationREITER, Rosemarie A; VARADI, Katalin; TURECEK, Peter L et al.Thrombosis and haemostasis. 2005, Vol 93, Num 3, pp 554-558, issn 0340-6245, 5 p.Article

Transcriptional regulation of ADMATSI3CLAUS, Ralf A; BOCKMEYER, Clemens L; KENTOUCHE, Karim et al.Thrombosis and haemostasis. 2005, Vol 94, Num 1, pp 41-45, issn 0340-6245, 5 p.Article

A novel binding site for ADAMTS 13 constitutively exposed on the surface of globular VWFZANARDELLI, Sara; CHION, Alain C. K; GROOT, Evelyn et al.Blood. 2009, Vol 114, Num 13, pp 2819-2828, issn 0006-4971, 10 p.Article

Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cellsLOPEZ, José A; DONG, Jing-Fei.Seminars in hematology. 2004, Vol 41, Num 1, pp 15-23, issn 0037-1963, 9 p.Article

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storageJACOBI, Paula M; COX GILL, Joan; FLOOD, Veronica H et al.Blood. 2012, Vol 119, Num 19, pp 4543-4553, issn 0006-4971, 11 p.Article

Expression of terminal α2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS 13MCGRATH, Rachel T; MCKINNON, Thomas A. J; BYRNE, Barry et al.Blood. 2010, Vol 115, Num 13, pp 2666-2673, issn 0006-4971, 8 p.Article

Amino acid residues Arg⁶⁵⁹, Arg⁶⁶⁰, and Tyr⁶⁶¹ in the spacer domain of ADAMTS 13 are critical for cleavage of von Willebrand factorJIN, Sheng-Yu; SKIPWITH, Christopher G; LONG ZHENG, X et al.Blood. 2010, Vol 115, Num 11, pp 2300-2310, issn 0006-4971, 11 p.Article

Force-induced cleavage of single VWF A1A2A3 tridomains by ADAMTS-13TAO WU; JIANGGUO LIN; CRUZ, Miguel A et al.Blood. 2010, Vol 115, Num 2, pp 370-378, issn 0006-4971, 9 p.Article

Inhibitory anti-ADAMTS 13 antibodies: Measurement and clinical applicationSCULLY, Marie.Blood reviews. 2010, Vol 24, Num 1, pp 11-16, issn 0268-960X, 6 p.Article

Essential role of the disintegrin-like domain in ADAMTS 13 functionDE GROOT, Rens; BARDHAN, Ajoy; RAMROOP, Nalisha et al.Blood. 2009, Vol 113, Num 22, pp 5609-5616, issn 0006-4971, 8 p.Article

Von willebrand factor antigen levels in Beh çet diseaseBEYAN, Esin; SADIKOGLU, Begüm; ERTUGRUL, Esin et al.American journal of hematology. 2005, Vol 79, Num 1, pp 70-72, issn 0361-8609, 3 p.Article

Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavageTURNER, Nancy A; NOLASCO, Leticia; RUGGERI, Zaverio M et al.Blood. 2009, Vol 114, Num 24, pp 5102-5111, issn 0006-4971, 10 p.Article

Expression and characterization of recombinant human ADAMTS-13PLAIMAUER, Barbara; SCHEIFLINGER, Friedrich.Seminars in hematology. 2004, Vol 41, Num 1, pp 24-33, issn 0037-1963, 10 p.Article

Assays of ADAMTS-13 activityVEYRADIER, Agnès; GIRMA, Jean-Pierre.Seminars in hematology. 2004, Vol 41, Num 1, pp 41-47, issn 0037-1963, 7 p.Article

Severe ADAMTS-13 deficiency in childhoodSCHNEPPENHEIM, Reinhard; BUDDE, Ulrich; HASSENPFLUG, Wolf et al.Seminars in hematology. 2004, Vol 41, Num 1, pp 83-89, issn 0037-1963, 7 p.Article

VWF-cleaving protease (ADAMTS13) in premature infantsHELLSTRÖM-WESTAS, Lena; LEY, David; BERG, Ann-Cathrine et al.Acta paediatrica (Oslo). 2005, Vol 94, Num 2, pp 205-210, issn 0803-5253, 6 p.Article

Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS 13JUNMEI CHEN; XIAOYUN FU; YI WANG et al.Blood. 2010, Vol 115, Num 3, pp 706-712, issn 0006-4971, 7 p.Article

Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease)MANNUCCIO MANNUCCI, Pier; KARIMI, Mehran; MOSALAEI, Ahmad et al.Haematologica (Roma). 2003, Vol 88, Num 4, pp 454-458, issn 0390-6078, 5 p.Article

Reduced von Willebrand Factor-Cleaving Protease Levels in Secondary Thrombotic Microangiopathies and Other DiseasesFRANCHINI, Massimo; MONTAGNANA, Martina; TARGHER, Giovanni et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 8, pp 787-797, issn 0094-6176, 11 p.Article

Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand factor A2 domain polypeptide as substrateCRUZ, Miguel A; WHITELOCK, Jody; DONG, Jing-Fei et al.Thrombosis and haemostasis. 2003, Vol 90, Num 6, pp 1204-1209, issn 0340-6245, 6 p.Article

The ADAMTS 13 metalloprotease domain: roles of subsites in enzyme activity and specificityDE GROOT, Rens; LANE, David A; CRAWLEY, James T. B et al.Blood. 2010, Vol 116, Num 16, pp 3064-3072, issn 0006-4971, 9 p.Article

Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesisNAKAYAMA, Takayuki; MATSUSHITA, Tadashi; YAMAMOTO, Koji et al.International journal of hematology. 2008, Vol 87, Num 4, pp 363-370, issn 0925-5710, 8 p.Article

Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related DiseasesHABE, Koji; WADA, Hideo; ITO-HABE, Naomi et al.Thrombosis research. 2012, Vol 129, Num 5, pp 598-602, issn 0049-3848, 5 p.Article